Announcement of Hubei Guangji Pharmaceutical: The company plans to pre-list and transfer 90% equity of its holding subsidiary Hubei Guangji Medical Technology Co., Ltd. on the Shanghai United Property Exchange. The current transaction is still in the planning stage, and the pre-listing is only for information disclosure to seek potential buyers and does not constitute a trading activity. The company still needs to carry out the formal public listing transfer of the above-mentioned shares on the Shanghai United Property Exchange after the assessment price filed and the corresponding deliberation procedures are completed. This transaction does not constitute a major asset reorganization, and the counterparty, transaction price, and other related matters have not been determined yet.